Stock Events

Stock Events

Heron Therapeutics (AXD2.F) Q3 2024 Earnings

6AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.14

-0.1

-0.06

-0.02

Details

Expected EPS

-0.035969718

Actual EPS

-0.054915599999999995

Surprise EPS

-0.02

Surprise Percent

+52.67%

Description

Heron Therapeutics (AXD2.F) has reported earnings of -0.054915599999999995 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.